tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY

Oncolytics Biotech (ONCY) Ownership - Who Owns Oncolytics Biotech?

985 Followers

Oncolytics Biotech (ONCY) Ownership Overview

The ownership structure of Oncolytics Biotech (ONCY) stock is a mix of institutional, retail and individual investors. Approximately 7.83% of the company’s stock is owned by Institutional Investors, 2.69% is owned by Insiders and 89.48% is owned by Public Companies and Individual Investors.
2.69% Insiders
0.05% Mutual Funds
7.78% Other Institutional Investors
89.48% Public Companies and
Individual Investors

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
672,900.00Insider0.92%942,060.00
314,863.00Insider0.43%440,808.20
189,941.00Insider0.26%265,917.40
127,238.00Insider0.17%178,133.20
96,333.00Insider0.13%134,866.20
90,000.00Insider0.12%126,000.00
63,761.00Insider0.09%89,265.40
54,700.00Insider0.07%76,580.00
53,000.00Insider0.07%74,200.00
48,948.00Insider0.07%68,527.20

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
34,659.00Institution0.05%48,522.60

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Oncolytics Biotech (ONCY)?
According to the latest TipRanks data, approximately 7.78% of the company's stock is held by institutional investors, 2.69% is held by insiders, and 89.48% is held by retail investors.
    What percentage of Oncolytics Biotech (ONCY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 7.78% of Oncolytics Biotech (ONCY) stock is held by institutional investors.
      What percentage of Oncolytics Biotech (ONCY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 89.48% of Oncolytics Biotech (ONCY) stock is held by retail investors.
        Who owns the most shares of Oncolytics Biotech (ONCY)?
        Bradley Thompson owns the most shares of Oncolytics Biotech (ONCY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis